Cargando…

Evaluation of a Novel Assay for Detection of the Fetal Marker RASSF1A: Facilitating Improved Diagnostic Reliability of Noninvasive Prenatal Diagnosis

BACKGROUND: Analysis of cell free fetal (cff) DNA in maternal plasma is used routinely for non invasive prenatal diagnosis (NIPD) of fetal sex determination, fetal rhesus D status and some single gene disorders. True positive results rely on detection of the fetal target being analysed. No amplifica...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Helen E., Dent, Carolyn L., Hall, Victoria J., Crolla, John A., Chitty, Lyn S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443218/ https://www.ncbi.nlm.nih.gov/pubmed/23024794 http://dx.doi.org/10.1371/journal.pone.0045073

Ejemplares similares

Noninvasive Prenatal Measurement of the Fetal Genome
por: Fan, H. Christina, et al.
Publicado: (2012)

The clinical utility of microarray technologies applied to prenatal cytogenetics in the presence of a normal conventional karyotype: a review of the literature
por: Callaway, Jonathan L A, et al.
Publicado: (2013)

Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome?
por: Hill, Melissa, et al.
Publicado: (2017)

Implementing Prenatal Diagnosis Based on Cell-Free Fetal DNA: Accurate Identification of Factors Affecting Fetal DNA Yield
por: Barrett, Angela N., et al.
Publicado: (2011)

Early noninvasive prenatal paternity testing by targeted fetal DNA analysis
por: Damour, Géraldine, et al.
Publicado: (2023)

Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta‐analysis
por: Mellis, Rhiannon, et al.
Publicado: (2022)

Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA
por: Chitty, Lyn S, et al.
Publicado: (2013)

Fetal Sex Results of Noninvasive Prenatal Testing and Differences With Ultrasonography
por: Dhamankar, Rupin, et al.
Publicado: (2020)

Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies
por: Jiang, Fuman, et al.
Publicado: (2012)

Model-Based Analysis of Costs and Outcomes of Non-Invasive Prenatal Testing for Down’s Syndrome Using Cell Free Fetal DNA in the UK National Health Service
por: Morris, Stephen, et al.
Publicado: (2014)

Hemolysis and Fetal Fraction in Cell-Free DNA Blood Collection Tubes for Noninvasive Prenatal Testing
por: Stokowski, Renee, et al.
Publicado: (2020)

Evidence for feasibility of fetal trophoblastic cell‐based noninvasive prenatal testing
por: Breman, Amy M., et al.
Publicado: (2016)

Noninvasive prenatal testing detects microdeletion abnormalities of fetal chromosome 15
por: Yin, Lianli, et al.
Publicado: (2019)

Bioinformatics Approaches for Fetal DNA Fraction Estimation in Noninvasive Prenatal Testing
por: Peng, Xianlu Laura, et al.
Publicado: (2017)

Clinical application of noninvasive prenatal testing in the detection of fetal chromosomal diseases
por: Pang, Yu, et al.
Publicado: (2021)

Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review
por: Deng, Cechuan, et al.
Publicado: (2022)

Noninvasive prenatal diagnosis targeting fetal nucleated red blood cells
por: Chen, Yanyu, et al.
Publicado: (2022)

High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening
por: Welker, Noah C., et al.
Publicado: (2020)

Diagnostic performance of the noninvasive prenatal FetoGnost RhD assay for the prediction of the fetal RhD blood group status
por: Legler, Tobias J., et al.
Publicado: (2021)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Noninvasive Prenatal Diagnosis of Fetal RHD Status Using Cell-free Fetal DNA in Maternal Plasma
por: Ahmadi, Mohammad Hossein, et al.
Publicado: (2022)

Efficiency of noninvasive prenatal testing for the detection of fetal microdeletions and microduplications in autosomal chromosomes
por: Pei, Yuanyuan, et al.
Publicado: (2020)

Inferring fetal fractions from read heterozygosity empowers the noninvasive prenatal screening
por: Dang, Minghao, et al.
Publicado: (2019)

Noninvasive prenatal prediction of fetal haplotype with Spearman rank correlation analysis model
por: Hanxiao, Du, et al.
Publicado: (2022)

Correction: Noninvasive prenatal diagnosis targeting fetal nucleated red blood cells
por: Chen, Yanyu, et al.
Publicado: (2023)

Stakeholder views and attitudes towards prenatal and postnatal transplantation of fetal mesenchymal stem cells to treat Osteogenesis Imperfecta
por: Hill, Melissa, et al.
Publicado: (2019)

Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders
por: Hanson, Britt, et al.
Publicado: (2022)

A qualitative study looking at informed choice in the context of non‐invasive prenatal testing for aneuploidy
por: Lewis, Celine, et al.
Publicado: (2016)

RAPIDR: an analysis package for non-invasive prenatal testing of aneuploidy
por: Lo, Kitty K., et al.
Publicado: (2014)

Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use?
por: Karampetsou, Evangelia, et al.
Publicado: (2014)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of women
por: Oxenford, Kerry, et al.
Publicado: (2013)

Calculating the fetal fraction for noninvasive prenatal testing based on genome‐wide nucleosome profiles
por: Straver, Roy, et al.
Publicado: (2016)

Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood
por: Zhang, Bin, et al.
Publicado: (2017)

Correction: Inferring fetal fractions from read heterozygosity empowers the noninvasive prenatal screening
por: Dang, Minghao, et al.
Publicado: (2019)

The impact of HBB‐related hemoglobinopathies carrier status on fetal fraction in noninvasive prenatal screening
por: Putra, Manesha, et al.
Publicado: (2022)

Offering non‐invasive prenatal testing as part of routine clinical service. Can high levels of informed choice be maintained?
por: Lewis, Celine, et al.
Publicado: (2017)

Combined fetal fraction to analyze the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18, and 21
por: Yang, Jiexia, et al.
Publicado: (2023)

Lessons learnt from prenatal exome sequencing
por: Chandler, Natalie J., et al.
Publicado: (2022)

Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol
por: Hill, Melissa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kmftjehe2lcdv31s6u9ne1t05n